Frottin, Frédéric <br/><br/>
MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state.  [electronic resource] 

 -  Oncotarget  Sep 2016 
 - 63306-63323 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.11216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopeptidases--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Cell Cycle<br/>Cell Division<br/>Cell Line, Tumor<br/>Cyclohexanes--chemistry<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Fatty Acids, Unsaturated--chemistry<br/>Gene Expression Regulation, Neoplastic<br/>Glutathione--chemistry<br/>Glycoproteins--metabolism<br/>Homeostasis<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Methionyl Aminopeptidases<br/>Oxidation-Reduction<br/>Phenotype<br/>Protein Domains<br/>Proteomics<br/>Sesquiterpenes--chemistry